← Leaderboards
Jacques Galipeau
Emory University
$3,962,786
Attributed
$3,962,786
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $897.4K · FY2012–19$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,962,786 · 2
By mechanism
R01$3,962,786 · 2
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Aron Lukacher$17,098,629
- E. John Wherry$31,162,830
- Rama Rao Amara$90,840,294
- Brian D. Evavold$24,193,113
- Shakira Franco Suglia$12,162,605
Others in their field
Top investigators on “Interleukin-10”
- Vijay K Kuchroo · Brigham And Women'S Hospital$21,107,356
- Lionel B Ivashkiv · Hospital For Special Surgery$20,754,555
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,144,108
- Abdolmohamad Rostami · Thomas Jefferson University$13,067,161
- Dennis J Hartigan-O'Connor · University Of California Los Angeles$12,967,881
- Robert L Modlin · University Of California Los Angeles$12,582,389
Research focus
Interleukin-10Mouse ModelImmune ResponseInterferonsIn VitroMedicalCytokineImmuneInflammatory Bowel DiseasesInnovationClinical TrialsAnimal ModelIn VivoLeadAcuteBiologyAutoimmune DiseasesHuman SubjectAutologousCellsBaseCell TherapyBiodistributionPhase 1 Study
Grant awards (11)
Cytokine primed autologous Mesenchymal Stromal Cells for therapy of colitis$512,893
R01 · FY2019 · DK · contact PI
Cytokine primed autologous Mesenchymal Stromal Cells for therapy of colitis$512,893
R01 · FY2018 · DK · contact PI
Cytokine primed autologous Mesenchymal Stromal Cells for therapy of colitis$512,893
R01 · FY2017 · DK · contact PI
Cytokine primed autologous Mesenchymal Stromal Cells for therapy of colitis$473,480
R01 · FY2016 · DK · contact PI
Inducible B-regulatory cells (iBREGs) for treatment of Multiple Sclerosis$291,364
R01 · FY2016 · AI · contact PI
Inducible B-regulatory cells (iBREGs) for treatment of Multiple Sclerosis$92,327
R01 · FY2016 · AI · contact PI
Cytokine primed autologous Mesenchymal Stromal Cells for therapy of colitis.$40,186
R01 · FY2016 · DK · contact PI
Inducible B-regulatory cells (iBREGs) for treatment of Multiple Sclerosis$387,500
R01 · FY2015 · AI · contact PI
Inducible B-regulatory cells (iBREGs) for treatment of Multiple Sclerosis$387,500
R01 · FY2014 · AI · contact PI
Inducible B-regulatory cells (iBREGs) for treatment of Multiple Sclerosis$364,250
R01 · FY2013 · AI · contact PI
Inducible B-regulatory cells (iBREGs) for treatment of Multiple Sclerosis$387,500
R01 · FY2012 · AI · contact PI